• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

准分子激光原位角膜磨镶术后角膜扩张症的两阶段序贯治疗:掀开角膜瓣下行角膜交联术以实现稳定,随后行角膜瓣表面地形图引导的准分子激光角膜切削术以优化视力。

Two-Staged Sequential Management of Post-LASIK Ectasia: Under-Flap Corneal Cross-Linking for Stabilization Followed by Flap Surface Topography-Guided PRK for Visual Optimization.

作者信息

Wallerstein Avi, Bellware Brandon, Cohen Mark, Demers Pierre, Gauvin Mathieu

机构信息

Department of Ophthalmology and Visual Sciences, McGill University, Montreal, QC H3A 0G4, Canada.

LASIK MD, Montreal, QC H3B 4W8, Canada.

出版信息

Biomedicines. 2025 May 21;13(5):1258. doi: 10.3390/biomedicines13051258.

DOI:10.3390/biomedicines13051258
PMID:40427084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12108988/
Abstract

: To evaluate the efficacy, accuracy, safety, and long-term stability of topography-guided photorefractive keratectomy (TGPRK) in eyes where post-LASIK (PLE) ectasia progression was stabilized with under-flap corneal crosslinking (ufCXL). : This retrospective interventional case series included six eyes from five patients with PLE after microkeratome LASIK. All eyes underwent ufCXL to halt ectatic progression. A shallow TGPRK enhancement was performed on the LASIK flap surface after corneal and refractive stability was confirmed (18 months median) post ufCXL Outcome measures included uncorrected and corrected distance visual acuity (UDVA, CDVA), spherical equivalent (SEQ), refractive astigmatism, keratometry, and corneal irregularity indices over a mean follow-up of 47 months. : ufCXL stabilized ectatic progression but left residual refractive errors, limiting UDVA. TGPRK performed subsequently significantly improved UDVA, from 0.38 to 0.10 LogMAR ( = 0.017), and increased the LASIK efficacy index from 0.46 to 0.83 ( = 0.0087). Refractive astigmatism was reduced in all eyes achieving a SEQ within ±1.00 D of the target. Long-term stability was maintained, with no ectasia progression, no change in SEQ, no change in corneal irregularity indices, and no increase in maximal keratometry. : TGPRK performed in ufCXL stabilized corneas can safely correct residual refractive errors, resulting in significant and sustained improvements in both refractive and visual outcomes in PLE.

摘要

评估在准分子原位角膜磨镶术(LASIK)后角膜扩张(PLE)进展通过瓣下角膜交联术(ufCXL)得以稳定的眼中,地形引导准分子激光角膜切削术(TGPRK)的疗效、准确性、安全性和长期稳定性。:这项回顾性干预病例系列研究纳入了5例接受微型角膜刀LASIK术后发生PLE的患者的6只眼。所有眼睛均接受ufCXL以阻止扩张进展。在确认ufCXL术后角膜和屈光稳定(中位时间18个月)后,在LASIK瓣表面进行了浅层TGPRK增强手术。结果指标包括平均随访47个月期间的未矫正和矫正远视力(UDVA、CDVA)、等效球镜度(SEQ)、屈光性散光、角膜曲率计测量值和角膜不规则指数。:ufCXL稳定了扩张进展,但留下了残余屈光不正,限制了UDVA。随后进行的TGPRK显著改善了UDVA,从0.38 LogMAR提高到0.10 LogMAR(P = 0.017),并将LASIK疗效指数从0.46提高到0.83(P = 0.0087)。所有达到目标SEQ在±1.00 D范围内的眼睛,屈光性散光均有所降低。维持了长期稳定性,未出现角膜扩张进展、SEQ无变化、角膜不规则指数无变化以及最大角膜曲率计测量值无增加的情况。:在ufCXL稳定的角膜上进行TGPRK可以安全地矫正残余屈光不正,从而在PLE患者中显著且持续地改善屈光和视觉效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a825/12108988/e437f1cefa01/biomedicines-13-01258-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a825/12108988/d92b44a681d6/biomedicines-13-01258-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a825/12108988/e437f1cefa01/biomedicines-13-01258-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a825/12108988/d92b44a681d6/biomedicines-13-01258-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a825/12108988/e437f1cefa01/biomedicines-13-01258-g002.jpg

相似文献

1
Two-Staged Sequential Management of Post-LASIK Ectasia: Under-Flap Corneal Cross-Linking for Stabilization Followed by Flap Surface Topography-Guided PRK for Visual Optimization.准分子激光原位角膜磨镶术后角膜扩张症的两阶段序贯治疗:掀开角膜瓣下行角膜交联术以实现稳定,随后行角膜瓣表面地形图引导的准分子激光角膜切削术以优化视力。
Biomedicines. 2025 May 21;13(5):1258. doi: 10.3390/biomedicines13051258.
2
Three-Year Outcomes of Under-flap Stromal Bed CXL for Early Post-LASIK Ectasia.经 LASIK 术后早期扩张性角膜病变行下基质床交联术的 3 年疗效。
J Refract Surg. 2022 Aug;38(8):511-519. doi: 10.3928/1081597X-20220713-01. Epub 2022 Aug 1.
3
Under-flap stromal bed CXL for early post-LASIK ectasia: a novel treatment technique.LASIK术后早期角膜扩张症的瓣下基质床角膜交联术:一种新的治疗技术。
Clin Ophthalmol. 2016 Dec 16;11:1-8. doi: 10.2147/OPTH.S118831. eCollection 2017.
4
Corneal collagen cross-linking for ectasia after LASIK and photorefractive keratectomy: long-term results.LASIK 和光性折射性角膜切削术后角膜扩张症的胶原交联:长期结果。
Ophthalmology. 2013 Jul;120(7):1354-9. doi: 10.1016/j.ophtha.2012.12.027. Epub 2013 Apr 10.
5
One-year visual and astigmatic outcomes of keratoconus patients following sequential crosslinking and topography-guided surface ablation: the TOPOLINK study.交联联合角膜地形图引导表层切削术后圆锥角膜患者 1 年的视力和散光结果:TOPOLINK 研究。
J Cataract Refract Surg. 2020 Apr;46(4):507-516. doi: 10.1097/j.jcrs.0000000000000110.
6
Intrastromal Corneal Ring Segment Implantation Followed by Simultaneous Topography-Guided Photorefractive Keratectomy and Corneal Cross-Linking for Contact Lens-Intolerant Keratoconus.基质内角膜环段植入联合角膜地形图引导的准分子激光角膜切削术和角膜交联术治疗接触镜不能耐受的圆锥角膜
Cornea. 2024 Mar 1;43(3):307-314. doi: 10.1097/ICO.0000000000003354. Epub 2023 Aug 4.
7
Does Adjunctive Under-flap CXL Reduce Regression for Hyperopic LASIK?辅助瓣下角膜交联术能否降低远视性LASIK术后的回退?
J Refract Surg. 2022 Dec;38(12):770-779. doi: 10.3928/1081597X-20221026-05. Epub 2022 Dec 1.
8
Clinical results of topography-based customized ablations in highly aberrated eyes and keratoconus/ectasia with cross-linking.基于地形的定制消融术在高度像差眼和交联治疗的圆锥角膜/扩张症中的临床效果。
J Refract Surg. 2012 Nov;28(11 Suppl):S841-8. doi: 10.3928/1081597X-20121005-06.
9
Wavefront excimer laser refractive surgery for adults with refractive errors.波前像差引导的准分子激光屈光手术治疗屈光不正的成年人。
Cochrane Database Syst Rev. 2020 Dec 18;12(12):CD012687. doi: 10.1002/14651858.CD012687.pub2.
10
Results of corneal collagen cross-linking in patients with corneal ectasia after laser refractive surgery-A prospective study.激光屈光手术后角膜扩张患者的角膜胶原交联结果——一项前瞻性研究。
Photodiagnosis Photodyn Ther. 2023 Jun;42:103521. doi: 10.1016/j.pdpdt.2023.103521. Epub 2023 Mar 16.

本文引用的文献

1
Long Term Corneal Flattening After Corneal Crosslinking in Patients with Progressive Keratoconus.进行性圆锥角膜患者角膜交联术后的长期角膜扁平化
Clin Ophthalmol. 2023 Jul 3;17:1865-1875. doi: 10.2147/OPTH.S409009. eCollection 2023.
2
Three-Year Outcomes of Under-flap Stromal Bed CXL for Early Post-LASIK Ectasia.经 LASIK 术后早期扩张性角膜病变行下基质床交联术的 3 年疗效。
J Refract Surg. 2022 Aug;38(8):511-519. doi: 10.3928/1081597X-20220713-01. Epub 2022 Aug 1.
3
Hypo-osmolar accelerated corneal crosslinking on resultant sub-400 μm topography-guided excimer regularized keratoconus corneas.
低渗加速角膜交联在400μm以下地形图引导的准分子激光角膜切削术矫正圆锥角膜后的角膜上的应用
J Cataract Refract Surg. 2022 Dec 1;48(12):1366-1374. doi: 10.1097/j.jcrs.0000000000000993.
4
Corneal flattening following collagen crosslinking for keratoconus: Findings at 5-year follow-up.角膜交联治疗圆锥角膜后角膜变平:5 年随访结果。
Eur J Ophthalmol. 2021 Jul;31(4):1525-1531. doi: 10.1177/1120672120964080. Epub 2020 Nov 2.
5
10-Year Results of Standard Cross-Linking in Patients with Progressive Keratoconus in Romania.罗马尼亚圆锥角膜患者标准交联手术的10年随访结果
J Ophthalmol. 2019 Mar 7;2019:8285649. doi: 10.1155/2019/8285649. eCollection 2019.
6
Under-flap stromal bed CXL for early post-LASIK ectasia: a novel treatment technique.LASIK术后早期角膜扩张症的瓣下基质床角膜交联术:一种新的治疗技术。
Clin Ophthalmol. 2016 Dec 16;11:1-8. doi: 10.2147/OPTH.S118831. eCollection 2017.
7
Ectasia risk factors in refractive surgery.屈光手术中的扩张风险因素。
Clin Ophthalmol. 2016 Apr 20;10:713-20. doi: 10.2147/OPTH.S51313. eCollection 2016.
8
Lasik Xtra Provides Corneal Stability and Improved Outcomes.准分子激光原位角膜磨镶术联合角膜基质内透镜植入术可提供角膜稳定性并改善手术效果。
Ophthalmol Ther. 2015 Oct 26;4(2):89-102. doi: 10.1007/s40123-015-0039-x.
9
Corneal collagen crosslinking with riboflavin and ultraviolet-A light in progressive keratoconus: ten-year results.核黄素和紫外线A光角膜交联治疗进展期圆锥角膜:十年结果
J Cataract Refract Surg. 2015 Jan;41(1):41-6. doi: 10.1016/j.jcrs.2014.09.033.
10
Corneal ectasia after myopic laser in situ keratomileusis: a long-term study.近视激光原位角膜磨镶术后角膜扩张:一项长期研究
Clin Ophthalmol. 2012;6:1801-13. doi: 10.2147/OPTH.S37249. Epub 2012 Nov 2.